J Rockstroh

Management of Progressive Outer Retinal Necrosis with Cidofovir in a Human Immunodeficiency Virus-Infected Patient

K. Schliefer, H Gümbel, J Rockstroh et al. · Clinical Infectious Diseases · 1999 · 21 citations

Ocular Disease, Vitreous Body, Ophthalmology +7

Clinical Outcomes of 2-Drug Regimens vs 3-Drug Regimens in Antiretroviral Treatment–Experienced People Living With Human Immunodeficiency Virus

Lauren Greenberg, Lene Ryom, Bastian Neesgaard et al. · Clinical Infectious Diseases · 2020 · 20 citations · Full text

The DAD Study Group. Combination antiretroviral therapy and the risk of myocardial infarction

Nina Friis‐Møller, Caroline Sabin, Reinhold Weber et al. · 2003 · 17 citations

Hiv/aids Counselling, Cardiovascular Disease, Treatment And Prevention +9

Week 48 Resistance Analyses of the Once-Daily, Single-Tablet Regimen Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Adults Living with HIV-1 from the Phase III Randomized AMBER and EMERALD Trials

Erkki Lathouwers, Eric Wong, Kimberley Brown et al. · AIDS Research and Human Retroviruses · 2019 · 13 citations · Full text

Elvitegravir/cobicistat/emtricitabine/tenofovir DF (Quad) has durable efficacy and differentiated safety compared to atazanavir boosted by ritonavir plus emtricitabine/tenofovir DF at week 96 in treatment‐naïve HIV‐1‐infected patients

J Rockstroh, E DeJesus, Kenneth R. Henry et al. · Journal of the International AIDS Society · 2012 · 11 citations · Full text

Week 48, Immunology, Pharmacotherapy +20